Clinical Trial Update: Phenylbutyrate in Proteinuric Nephropathies [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update indicates completion of Phase 2 and Phase 3 studies evaluating phenylbutyrate in proteinuric nephropathies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proteinuric Nephropathies

Drugs mentioned

• Phenylbutyrate (phenylbutyrate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Proteinuric Diseases | Phase 2, Phase 3 | Status: COMPLETED